140 related articles for article (PubMed ID: 9213647)
21. Can we really believe that aprotinin is safe in congenital heart surgery?
Faraoni D
Ann Thorac Surg; 2011 Mar; 91(3):987-8; author reply 988. PubMed ID: 21353050
[No Abstract] [Full Text] [Related]
22. Blood conservation in liver transplantation: The role of aprotinin.
Porte RJ; Hendriks HG; Slooff MJ
J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):31S-37S. PubMed ID: 15368204
[No Abstract] [Full Text] [Related]
23. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
Bizouarn P
Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
[No Abstract] [Full Text] [Related]
24. Role of leukocytes in hemostasis during orthotopic liver transplantation.
Riess H; Jochum M; Machleidt W; Himmelreich G; Bechstein WO; Muser M; Neuhaus P; Roissant R; Huhn D
Semin Thromb Hemost; 1993; 19(3):197-208. PubMed ID: 7689749
[No Abstract] [Full Text] [Related]
25. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Beattie WS; Karkouti K
Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
[No Abstract] [Full Text] [Related]
26. ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?
Kan CD
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):622; discussion 622. PubMed ID: 17884856
[No Abstract] [Full Text] [Related]
27. [Aprotinin -- an allogeneic transfusion sparing drug].
Haas S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):38-40. PubMed ID: 12522728
[No Abstract] [Full Text] [Related]
28. The demise of aprotinin: our share of the blame.
Sundt TM
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):729-31. PubMed ID: 18374748
[No Abstract] [Full Text] [Related]
29. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
Langdown AJ; Field J; Grote J; Himayat H
J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin: twenty-five years of claim and counterclaim.
Westaby S
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):487-91. PubMed ID: 18329457
[No Abstract] [Full Text] [Related]
31. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation.
Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P
Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756
[No Abstract] [Full Text] [Related]
32. Factor XIII activity during orthotopic liver transplantation.
Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
[No Abstract] [Full Text] [Related]
33. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
Augoustides JG
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
[No Abstract] [Full Text] [Related]
34. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery.
Booth D; Kothmann E; Tidmarsh M
J Bone Joint Surg Br; 2004 Mar; 86(2):309-10; author reply 310. PubMed ID: 15046454
[No Abstract] [Full Text] [Related]
35. Pro: aprotinin should be used in patients undergoing hypothermic circulatory arrest.
Royston D
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):121-5. PubMed ID: 11254854
[No Abstract] [Full Text] [Related]
36. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
Hill SE
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
[No Abstract] [Full Text] [Related]
37. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Body SC; Mazer CD
Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
[No Abstract] [Full Text] [Related]
38. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation.
Mallett S; Rolles K; Cox D; Burroughs A; Hunt B
Transplant Proc; 1991 Jun; 23(3):1931-2. PubMed ID: 1712134
[No Abstract] [Full Text] [Related]
40. Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin.
Liu CM; Chen J; Wang XH
World J Gastroenterol; 2008 Mar; 14(9):1425-9. PubMed ID: 18322960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
